The effect of sodium-glucose co-transporter 2 inhibitors on clinical outcomes after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials

Figures

• 

  Figure 1.. PRISMA flow chart of the screening process.

• 

  Figure 2.. Quality assessment of risk of bias in the included trials. The upper panel presents a schematic representation of risks (low = green, unclear = yellow, and high = red) for specific types of biases of each of the studies in the review. The lower panel presents risks (low = green, unclear = yellow, and high = red) for the subtypes of biases of the combination of studies included in this review.

• 

  Figure 3.. Forest plot of the primary outcomes, RR: risk ratio, CI: confidence interval.

• 

  Figure 4.. Forest plot of the clinical outcomes, RR: risk ratio, CI: confidence interval.

• 

  Figure 5.. Forest plot of the other parameters, MD: mean difference, RR: risk ratio, CI: confidence interval.

• 

  Figure 6.. Forest plot of the safety outcomes, RR: risk ratio, CI: confidence interval.